Cloud Computing

When: Wed, Jun 6, 2018 10:00 AM - 11:00 AM PDT Register Now   PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in determining...

Another day, another day of pathology artificial intelligence (AI) news. This recently from Proscia in partnership with Proteocyte AI. Proscia Inc., creators of AI-powered digital pathology software, and Proteocyte AI, a company designing...

OR

platinum partners

gold partners

Silver Partners

Media Partners